Estrigenix CSO Dr. Karyn Frick represented the University of Wisconsin-Milwaukee today at the Universities of Wisconsin press conference about the vital importance of federally funded research to education, health, and the economy. NIH support has been absolutely invaluable to advancing Estrigenix's technology and we hope to see this support continue. ”Federal funding for basic and clinical research is critical for training new scientists and health professionals while developing new treatments for devastating neurological diseases,” Frick said. “Simply put, these desperately needed treatments would not be possible without NIH funding.” A video recording of the entire news conference can be found here:?https://lnkd.in/g_W8rifE
Estrigenix Therapeutics, Inc.
制药业
Milwaukee ，WI 330 位关注者
Improving women’s health through targeted chemistry
关于我们
Estrigenix Therapeutics, Inc. is a privately held pharmaceutical company developing the next generation of innovative therapies for improving the mental health of menopausal women. Menopause is associated with cognitive dysfunction, increased mood and anxiety disorders, and an elevated risk of Alzheimer’s disease, yet standard estrogen therapies are associated with increased risks of cancer, heart disease, and stroke. Our mission is to develop novel drugs that mitigate the adverse effects of menopause on mental health and enable women to live healthier and happier lives. The drug development program at Estrigenix focuses on selectively activating specific estrogen receptor proteins that promote memory formation, improve mood, and reduce anxiety. We believe that targeting these receptors will provide the cognitive and mood-enhancing benefits of estrogens without the harmful side effects of standard estrogen therapies. Our lead compound, EGX-358, is a potent and selective agonist of the estrogen receptor beta protein, which enhances memory formation in a mouse model of menopause. Current work is expanding the use of this compound to other indications, including depression, anxiety, and hot flashes.
- 网站
-
https://estrigenix.com
Estrigenix Therapeutics, Inc.的外部链接
- 所属行业
- 制药业
- 规模
- 2-10 人
- 总部
- Milwaukee ，WI
- 类型
- 合营企业
- 创立
- 2018
地点
-
主要
获取路线
US，WI，Milwaukee ，53201
Estrigenix Therapeutics, Inc.员工
动态
-
Estigenix is proud to announce that CSO Dr. Karyn Frick was an honored guest at yesterday's White House Conference on Women's Health Research! We are fortunate to have Dr. Frick's expertise in estrogen biology to help guide our product development.
-
-
We’re excited that Estrigenix is one of 4 companies selected to pitch tonight in the Healthcare category at Southeast WI’s 6th Healthcare Innovation Pitch! Good luck to CEO William Donaldson!
Startup, Music & Creative Economy Nerd | Strategist | Advisor | Connector | Podcast Host | Speaker (2x TEDx)
?? Tonight’s the Night! ?? Southeast Wisconsin’s 6th Annual Healthcare Innovation Pitch ?? When: Tonight, November 21 ?? Where: Eagleknit Innovation Hub, 507 S 2nd St, Milwaukee, WI ? Time: 5:30 PM - 9:00 PM RSVP:https://lnkd.in/gC5FNy6i What to Expect: ? Healthcare & HealthTech Startups pitching for $50,000+ in funding and resources ? Networking with top-tier angel and venture investors ? Insights from last year’s winner, Sanacor, on securing seed funding ? The debut of the program’s #Mi2Wi Track, aimed at better connecting the healthcare innovation ecosystems across Michigan and Wisconsin ?? Watch the video to hear directly from the founders as they share their groundbreaking visions. Whether you’re a founder, an investor, or someone inspired by cutting-edge healthcare solutions, this is your chance to connect and contribute to a thriving ecosystem. Like, share, and tag someone in the comments you know is passionate about improving the healthcare industry so we can pack the room for these founders tonight! ?? MaternityMetrix / Freyja, Inc. (AkkeNeel Talsma) ?? UbiVital (Karen Wurzel) ??Streamline Flow (Kelly A.) ??Advanced Trauma Analytics (Rachel Morris) ??Inrova Mobile Technology (Dr. John Burfeind) ??Synpha Biosciences (Phil Huss) ??CoMotions (Christian Kastrup) ??Estrigenix Therapeutics, Inc. (William Donaldson) ??SmileBOND (William C Vuillemot DDS) ??BetterPlay Studios, Inc. Play (Vanessa Lane) #HealthcareInnovationPitch #HealthTech #HealthcareInnovation #Startups #Milwaukee #Wisconsin #Networking #Investors #Founders #Pitch #Mi2Wi These (and many more) folks and orgs have made it all possible this year ?? Daniel Sem, Jessica Silvaggi, Kalpa Vithalani, Kristin Ciezki, Landon Olp, Scott Bolte, MCW Therapeutic Accelerator Program, CTSI of Southeast Wisconsin, MKE Tech Hub Coalition, BioForward, Inc., Wisconsin Economic Development Corporation
-
A fantastic opportunity to work with our CSO! Please share with your networks!
I’m #hiring a postdoc to work on my NIH grant to study estrogenic regulation of brain function! Come work with us!
此处无法显示此内容
在领英 APP 中访问此内容等
-
The Estrigenix team is excited to share our latest research which shows that Estrigenix Therapeutics, Inc. compound EGX358 enhances memory and reduces hot flashes in a female mouse model of Alzheimer's disease without negative side effects on anxiety, body weight, or uterine weights! This work was conducted by a large interinstitutional team led by CSO Karyn Frick that includes Miranda Schwabe, Aaron Fleischer, William Donaldson, Daniel Sem, and Subhabrata Chaudhury! https://lnkd.in/gN7ABVz9